Hangzhou AGS MedTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	599.86	588.02	632.86	506.09	368.92	305.1
Other Revenue	5.72	5.72	3.78	2.65	2.2	0.37
Revenue	605.58	593.74	636.63	508.75	371.11	305.47
Revenue Growth (YoY)	-7.36%	-6.74%	25.14%	37.09%	21.49%	77.64%
Cost of Revenue	179.21	173.94	180.84	149.86	119.38	108.54
Gross Profit	426.37	419.8	455.79	358.89	251.73	196.92
Selling, General & Admin	122.61	124.4	108.89	95.38	66.59	53
Research & Development	78.55	75.89	59.21	41.25	31.46	24.19
Other Operating Expenses	13.41	8.55	6.09	1.39	3.29	2.43
Operating Expenses	214.24	209.13	173.69	140.17	101.63	79.83
Operating Income	212.13	210.68	282.11	218.72	150.1	117.09
Interest Expense	-0.16	-0.11	-0.05	-	-	-
Interest & Investment Income	52.15	45.76	55.23	28.91	2.59	2.52
Currency Exchange Gain (Loss)	-6.03	-6.03	0.32	0.69	11.1	-4.24
Other Non Operating Income (Expenses)	-7.27	-0.4	1.24	-1.05	-0.84	-0.14
EBT Excluding Unusual Items	250.82	249.91	338.85	247.28	162.95	115.23
Gain (Loss) on Sale of Investments	4.58	2.51	2.08	0.41	-7.19	1.09
Gain (Loss) on Sale of Assets	-0.33	-0.3	-0.2	-0.8	-0.14	-0.01
Asset Writedown	-2.03	-	-	-	-0	-0.14
Other Unusual Items	10.02	9.93	2.87	4.78	9.94	3.79
Pretax Income	263.06	262.05	343.6	251.67	165.56	119.97
Income Tax Expense	41.3	40.61	50.21	34.43	20.6	15.17
Earnings From Continuing Operations	221.76	221.44	293.39	217.24	144.96	104.8
Minority Interest in Earnings	0.5	0.28	-	-	-	-
Net Income	222.26	221.71	293.39	217.24	144.96	104.8
Net Income to Common	222.26	221.71	293.39	217.24	144.96	104.8
Net Income Growth	-25.13%	-24.43%	35.06%	49.86%	38.32%	131.68%
Shares Outstanding (Basic)	80	80	81	73	61	61
Shares Outstanding (Diluted)	80	80	81	73	61	61
Shares Change (YoY)	-0.35%	-0.13%	11.02%	19.46%	-	-
EPS (Basic)	2.77	2.76	3.64	2.99	2.39	1.72
EPS (Diluted)	2.76	2.75	3.64	2.99	2.39	1.72
EPS Growth	-24.87%	-24.33%	21.65%	25.44%	38.60%	131.71%
Free Cash Flow	132.51	87.74	266.19	169.88	96.26	102.59
Free Cash Flow Per Share	1.65	1.09	3.30	2.34	1.58	1.69
Dividend Per Share	1.039	1.039	1.373	1.036	0.543	-
Dividend Growth	-24.35%	-24.35%	32.62%	90.77%	-	-
Gross Margin	70.41%	70.70%	71.59%	70.54%	67.83%	64.47%
Operating Margin	35.03%	35.48%	44.31%	42.99%	40.45%	38.33%
Profit Margin	36.70%	37.34%	46.09%	42.70%	39.06%	34.31%
Free Cash Flow Margin	21.88%	14.78%	41.81%	33.39%	25.94%	33.59%
EBITDA	224.72	222.59	291.28	225.29	154.82	121.17
EBITDA Margin	37.11%	37.49%	45.75%	44.28%	41.72%	39.67%
D&A For EBITDA	12.59	11.91	9.17	6.56	4.72	4.07
EBIT	212.13	210.68	282.11	218.72	150.1	117.09
EBIT Margin	35.03%	35.48%	44.31%	42.99%	40.45%	38.33%
Effective Tax Rate	15.70%	15.50%	14.61%	13.68%	12.44%	12.64%
Revenue as Reported	605.58	593.74	636.63	508.75	371.11	-